You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Nature this week: method to uncover genetic components of complex traits, novel cytosine base editor, and more.
A pilot project showed that clinics using the InheRET tool were able to gather more complete family history information from patients, which is important for further cancer risk evaluation.
In Nucleic Acids Research this week: prostate cancer drugs' effect on androgen receptors, approach to gauge effects of epigenetic drugs, and more.
In Nature this week: sequencing analysis finds some cells in the lungs of former smokers have mutational burdens that were equivalent to those of never-smokers, and more.
In a large group of participants followed for decades, baseline body mass index outperformed a SNP-based obesity risk score for predicting midlife weight.
In Nature this week: residual protein expression uncovered for a third of CRISPR targets, and more.
Cytek believes the updated Aurora platform, which the company says can resolve 40 colors, may curb errors and costs for spectral analysis.
With exome sequences for tens of thousands of Finns, researchers identified deleterious variants linked to dozens of clinically relevant quantitative traits.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.
The Genes for Good Project has engaged 80,000 Facebook users via its online application and genotyped 27,000 people to date.
New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.
A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.